HOTH News and Press, Hoth Therapeutics Inc. From 01/04/21

Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command (USAMRDC) for Treating Multi-Drug Resistant Bacterial Lung Infections License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Re...

Gainers: Hoth Therapeutics (HOTH) +49%. Bionano Genomics (BNGO) +38%. Clearside Biomedical (CLSD) +17%. Regional Health Properties (RHE) +14%. Ampio Pharmaceuticals (AMPE) +13%.Losers: Histogen (HSTO) -26%. Novan (NOVN) -22%. ORIC Pharmaceuticals (ORIC) -14%. DermTech (DMTK) -12%. T...

Biopharmaceutical company Hoth Therapeutics (HOTH) has signed a production agreement for both GLP and GMP materials associated with HT-001 with Tergus Pharma for its novel cancer treatment. The update follows the recent news that Hoth has requested a Pre-Investigational New Drug ((IND)) meeti...

Ashford (AINC) +75%.PEDEVCO (PED) +62%.SGOCO (SGOC) +49%.Ebang International Holdings (EBON) +33%.Red Lion Hotels RLH +31% on being acquired by Sonesta.Canaan (CAN) +30%.AirNet Technology (ANTE) +25%.Hudson Capital HUSN +24% as FreightHub posts stellar Q3 results.Hoth Ther...

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment PR Newswire NEW YORK , Dec. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has signed a production agreement for both GLP ...

Hoth Therapeutics Submits Request for a Pre-Investigational New Drug (Pre-IND) Meeting for HT-001, Treatment for Cancer Patients PR Newswire NEW YORK , Dec. 23, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company,&#x...

Endocannabinoid Pathway Targeted Drug Demonstrates Proof-of-Concept Efficacy in a Cutaneous Lupus Erythematosus Mouse Model PR Newswire NEW YORK , Dec. 21, 2020 /PRNewswire/ -- Hoth (NASDAQ: HOTH) has a partnership agreement with Zylö Therapeutics Inc....

Hoth Therapeutics, Inc. (HOTH) has been granted the approval to advance its Phase 1b clinical trial of BioLexa Lotion for the treatment of mild to moderate atopic dermatitis in Australia.The approval by the Human Research Ethics Committee in Australia is a “critical milestone towards i...

Hoth Therapeutics Receives Approval to Commence Phase 1b Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans NEW YORK , Dec. 10, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH ), a biopharmaceutical company, today announce...

Immutep (IMMP) +132% after breast cancer trial shows promising survival data.Greenwich LifeSciences (GLSI) +57%.UTStarcom Holdings (UTSI) +50%.Panbela Therapeutics (PBLA) +46%.Leju Holdings (LEJU) +38%.SELLAS Life Sciences (SLS) +36%.ClearOne (CLRO) +35% to expand its footprint in M...